whether patients should undergo genetic testing to determine their warfarin dose

  Experts are now debating whether patients should undergo genetic testing to determine their warfarin dose.

  Warfarin doses are mostly titrated by trial and error.

  Now the FDA is suggesting lower doses for patients with certain genetic variations.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote